panipenem-betamipron has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horiike, S; Iwai, T; Kashima, K; Kobayashi, M; Misawa, S; Nakazawa, N; Ohkawara, Y; Okamoto, T; Sasai, Y; Tamura, A; Taniwaki, M; Tuda, S; Yokota, S | 1 |
1 trial(s) available for panipenem-betamipron and Multiple Myeloma
Article | Year |
---|---|
[Clinical evaluation of panipenem/betamipron as a second line chemotherapy in severe infections associated with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; beta-Alanine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pneumonia; Pyelonephritis; Sepsis; Thienamycins; Treatment Outcome | 1998 |